| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |